Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
12/14/1999 | US6001597 Yeast cell in which an alcohol oxidase gene is defective; for preparing exogenous proteins |
12/14/1999 | US6001596 Growth-associated protease inhibitor heavy chain precursor |
12/14/1999 | US6001592 Polypeptide gene cDNA, vector containing said cDNA, host cells transformed with said vector, method of producing said polypeptide, DNA encoding said polypeptide |
12/14/1999 | US6001591 Recombinant bovine adenoviruses |
12/14/1999 | US6001590 Promoter and terminator sequences of formate dehydrogenase gene of Candida boidinii |
12/14/1999 | US6001589 Selecting tumor, cancer, or cultured cells; cloning a portion of a nucleotide sequence which encodes a protein of interest; sequencing the cloned nucleotide sequence and predicting the amino acid sequence; comparing to non-diseased cells |
12/14/1999 | US6001588 Dna sequence coding mutant cystic fibrosis gene polypeptide; for screening patient to determine if person is cf carrier; for developing immunoassay for detecting cystic fibrosis |
12/14/1999 | US6001584 Detecting a cell with terminal kinase activity; contacting a cell component associated with terminal kinase with antibody and detecting interaction; antiproliferative agents |
12/14/1999 | US6001582 Detecting chemical modulator for activation of gene expression; expressing protein, preparing a complex with protein and nuclear factor, incubation with modulator, detect adjusted gene expression; |
12/14/1999 | US6001581 Cation-based bioassay using human metabotropic glutamate receptors |
12/14/1999 | US6001577 Systematic evolution of ligands by exponential enrichment: photoselection of nucleic acid ligands and solution selex |
12/14/1999 | US6001576 Diagnosing hereditary nervous system disease in humans; using sequence analysis to detect mutation in connexin-32 gene |
12/14/1999 | US6001575 Nucleic acid sequences coding glutamate receptor interacting protein; for detecting glutamate receptor in tissues and screening receptor modulating drugs; diagnosis and therapy for infertility, nervous system and memory defects |
12/14/1999 | US6001574 Constructing a genomic deoxyribonucleic acid library from an exogenous sample; obtaining exogenous genomic sample, amplifying genomic sample, calibrating genomic library; for screening libraries of mixed microorganism samples |
12/14/1999 | US6001567 Detection of nucleic acid sequences by invader-directed cleavage |
12/14/1999 | US6001566 DNA polymerase having 3'-intrinsic editing activity |
12/14/1999 | US6001565 Testing for the presence of campylobacter in a clinical, environmental or food samples; performing polymerase chain reaction and screening for reaction product; efficient detection and distinction between campylobacter species |
12/14/1999 | US6001564 Using oligionucleotides to determine quanity of nucleic acids; contacting sample with oligonucleotides, detecting hybridized complexes or amplified bacterial products with antibiotic resistance gene; for the detection of parasites |
12/14/1999 | US6001563 Detecting a substance which sensitizes cell to therapeutic agent; contacting transfected cell with drug in vitro, determining resistance to drug, detecting sensitizer; for reversing drug resistance in cells; anticarcinogenic agents |
12/14/1999 | US6001560 Stably-transformed human cell lines containing a human gamma interferon-responsive human hla-dr alpha promoter operatively linked to a reporter gene for use in screening for agonists or antagonists of human gamma interferon |
12/14/1999 | US6001558 Amplification and detection of HIV-1 and/or HIV 2 |
12/14/1999 | US6001557 Polycation conjugate coding defective virus which reduces the packaging efficiency virus, a minigene and sequences which allow for efficiect viral infection; for gene therapy |
12/14/1999 | US6001553 Saccharomyces cell engineered to express chimeric human signal transduction enzyme and g protein; for detection of enzyme inhibitors or activators |
12/14/1999 | US6001371 Relates to recombinant baculoviruses encoding parvovirus structural proteins and host cells infected therewith; method of packaging and delivering genetic information utilizing the noninfectious capsids |
12/14/1999 | US6001369 Recombinant fowlpox virus comprising a foreign dna inserted into the fowlpox virus genomic dna, wherein the foreign dna sequence is inserted within a fragment of the fowlpox virus genomic dna and is capable of being expressed in host cell |
12/14/1999 | US6001363 Eimeria protein with immunogenic properties; dna encoding this protein can be used for the preparation of a vector vaccine against coccidiosis |
12/14/1999 | US6001362 Treatment of an individual in need of response regulator polypeptide comprising administering to the individual a therapeutically effective amount of a polypeptide comprising given amino acid sequence |
12/14/1999 | US6001361 For the prevention, treatment and diagnosis of mycobacterial infection, together with adjuvants for use in vaccines or immunotherapy of infectious diseases and cancers; for preventing, treating and detecting tuberculosis |
12/14/1999 | US6001358 Useful for treatment of autoimmune diseases |
12/14/1999 | US6001350 Genetic modification of endothelial cells |
12/14/1999 | US6001349 Generation of human cytotoxic T-cells specific for carcinoma self-associated antigens and uses thereof |
12/14/1999 | US6001309 Jet droplet device |
12/14/1999 | US6000772 Tubulin promoter regulates gene expression in neurons |
12/14/1999 | CA2186526C Method and product for regulating cell responsiveness to external signals |
12/14/1999 | CA2172137C Surface loop structural analogues of fibroblast growth factors |
12/14/1999 | CA2155024C Genetic modification of neural stem cells |
12/14/1999 | CA2135642C Tat-derived transport polypeptides |
12/14/1999 | CA2117795C Gustducin materials and methods |
12/14/1999 | CA2084186C Purification of human interleukin-4 secreted from a escherichia coli mutant |
12/14/1999 | CA2081028C Cd2 binding domain of lymphocyte function associated antigen 3 |
12/14/1999 | CA2078189C Mammalian artificial chromosomes |
12/14/1999 | CA2058216C Enzymatic process for preparing 7-aminocephalosporanic acid and derivatives |
12/14/1999 | CA2036913C A modified transcription control unit and uses thereof |
12/14/1999 | CA2020265C Method and apparatus for the acceleration of a propellable material |
12/14/1999 | CA2002890C Expression of dna sequences derived from nocardioform microorganisms |
12/14/1999 | CA1340852C Process for purifying primate gm-csf protein |
12/14/1999 | CA1340848C Pseudorabies virus protein |
12/14/1999 | CA1340847C Adhesin antigens |
12/12/1999 | CA2273047A1 New strains "fil", stress-resistant under fermentation and/or growth conditions |
12/12/1999 | CA2272599A1 Rice gene resistant to blast disease |
12/10/1999 | CA2254178A1 Atp-sensitive potassium channel gene-defective animals |
12/10/1999 | CA2253641A1 Dna fragment, recombinant dna, and transformed plant |
12/09/1999 | WO1999063118A1 Method, reagent and kit for genotyping of human papillomavirus |
12/09/1999 | WO1999063116A2 Use of prothymosin in the diagnosis and treatment of endometriosis |
12/09/1999 | WO1999063115A2 Use of cathepsin s in the diagnosis and treatment of endometriosis |
12/09/1999 | WO1999063114A1 Antisense oligonucleotide modulation of human thymidylate synthase expression |
12/09/1999 | WO1999063100A1 Process for obtaining transgenic plants which have an improved capacity for the uptake of nutrients and tolerance to toxic compounds which are present in the soil |
12/09/1999 | WO1999063099A1 Functional expression of adenosine receptors in yeast |
12/09/1999 | WO1999063098A1 Recombinant venezuelan equine encephalitis virus vaccine |
12/09/1999 | WO1999063097A2 Caspase-9 deficient animals and the use thereof |
12/09/1999 | WO1999063096A2 Acyl coa:cholesterol acyltransferase related nucleic acid sequences |
12/09/1999 | WO1999063095A1 Nucleic acid vaccines for prevention of flavivirus infection |
12/09/1999 | WO1999063094A2 Nucleotide and protein sequences of gpr1 and methods based thereon |
12/09/1999 | WO1999063093A2 Basb027 proteins and genes from moraxella catarrhalis, antigens, antibodies, and uses |
12/09/1999 | WO1999063092A1 Root-specific protein involved in auxin transport |
12/09/1999 | WO1999063091A1 Disulfide core polypeptides |
12/09/1999 | WO1999063090A2 Protease inhibitor peptides |
12/09/1999 | WO1999063089A1 Cyclin e2 genes and proteins |
12/09/1999 | WO1999063088A2 Membrane-bound proteins and nucleic acids encoding the same |
12/09/1999 | WO1999063087A1 G-protein coupled receptor, named 2871 receptor |
12/09/1999 | WO1999063086A2 Insulin-like growth factor binding protein-3 variants |
12/09/1999 | WO1999063085A1 IgA NEPHROPATHY-ASSOCIATED DNA |
12/09/1999 | WO1999063084A1 T cell antigen receptor sequences specific to arthrosis deformans |
12/09/1999 | WO1999063083A1 Novel gene and protein encoded thereby |
12/09/1999 | WO1999063082A2 Isolation of drosophila homolog to mammalian gdnf |
12/09/1999 | WO1999063081A2 Ion channels |
12/09/1999 | WO1999063080A1 HUMAN HOMOLOGUE OF UNC-53 PROTEIN OF $i(C. ELEGANS) |
12/09/1999 | WO1999063079A1 Endometriosis-associated gene |
12/09/1999 | WO1999063078A2 Retinal calcium channel (alpha)1f-subunit gene |
12/09/1999 | WO1999063077A2 Compositions of nucleic acid which alter ligand-binding characteristics and related methods and products |
12/09/1999 | WO1999063076A1 Novel method of large scale plasmid purification |
12/09/1999 | WO1999063075A1 Monoclonal antibodies and method for assaying fdp |
12/09/1999 | WO1999063074A2 Altering the ligand-binding characteristics of a nucleic acid ligand binding sequence by altering the nucleotide composition of its flanking sequences |
12/09/1999 | WO1999063071A2 Method for triggering apoptosis in cells |
12/09/1999 | WO1999063070A1 Human protein c polypeptide |
12/09/1999 | WO1999063069A1 Human mitochondrial processing protease beta subunit (mppb) homolog gene |
12/09/1999 | WO1999063068A1 Phenotype modifying genetic sequences |
12/09/1999 | WO1999063066A2 Amino-modified ribozymes |
12/09/1999 | WO1999063064A1 Novel methods for rescue of rna viruses |
12/09/1999 | WO1999063062A1 Genetically manipulated entomopoxvirus |
12/09/1999 | WO1999063061A1 Es cell lines from somatic cells via embryo reconstruction and selective ablation |
12/09/1999 | WO1999063059A1 Trans-activation of transcription from viral rna |
12/09/1999 | WO1999063055A1 Genes of carotenoid biosynthesis and metabolism and methods of use thereof |
12/09/1999 | WO1999063054A2 Mutant forms of the al2 gene of geminiviruses |
12/09/1999 | WO1999062954A1 A HUMAN MAGO GENE (h-MAGO) |
12/09/1999 | WO1999062953A1 A human leucine zipper protein gene (bmh) (cblayd06) |
12/09/1999 | WO1999062952A1 A human zinc finger protein gene (bmzf2) |
12/09/1999 | WO1999062951A1 A human zinc finger protein gene (bmzf3) |
12/09/1999 | WO1999062950A1 A human ubiquinone oxireductase subunit ci-aggg homolog gene (cbfakd10) |
12/09/1999 | WO1999062949A1 A human ubiquinone oxireductase subunit ci-b17 homolog gene (cblale02) |